These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11103598)

  • 1. Merck: committed to access to medicines for patients throughout the world.
    Gilmartin RV
    N J Med; 2000 Nov; 97(11):27-9. PubMed ID: 11103598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standards of acceptable manufacturing and inspection methods].
    Battaglino G
    Boll Chim Farm; 1984 Jun; 123(6):247-62. PubMed ID: 6497974
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug access in poor countries].
    Sebbag R
    Bull Acad Natl Med; 2007 Nov; 191(8):1601-2. PubMed ID: 18666459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 5. Access to essential medicines for children: the world health organization's global response.
    Zucker H; Rägo L
    Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 2002; 902():i-vii, 1-208. PubMed ID: 12082969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO wants safer medicines for children.
    Choonara I
    Arch Dis Child; 2008 Jun; 93(6):456-7. PubMed ID: 18495908
    [No Abstract]   [Full Text] [Related]  

  • 8. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

  • 9. Global health challenges in the pharmaceutical world.
    Abraham J
    Health Econ Policy Law; 2009 Jan; 4(Pt 1):115-27. PubMed ID: 19099620
    [No Abstract]   [Full Text] [Related]  

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
    Viana JM
    Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
    [No Abstract]   [Full Text] [Related]  

  • 12. Patently necessary: improving global access to essential medicines.
    CMAJ; 2003 Dec; 169(12):1257, 1259. PubMed ID: 14662658
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of pharmaceutical data exclusivity laws in Latin America: is access to affordable medicine threatened?
    Cartagena RG; Attaran A
    Health Law J; 2009; 17():269-96. PubMed ID: 20608321
    [No Abstract]   [Full Text] [Related]  

  • 14. World agencies try to stem flood of fake drugs.
    Surendran A
    Nat Med; 2004 Feb; 10(2):111. PubMed ID: 14760401
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1984; 704():1-54. PubMed ID: 6437087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 20. Making medicines and health technologies safe and accessible.
    Lepakhin V
    Bull World Health Organ; 2005 Sep; 83(9):648-9. PubMed ID: 16222763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.